Advertisement
New Zealand markets open in 54 minutes

  • NZX 50

    11,946.43
    +143.15 (+1.21%)
     

  • NZD/USD

    0.5952
    +0.0015 (+0.26%)
     

  • ALL ORDS

    7,937.50
    -0.40 (-0.01%)
     

  • OIL

    83.78
    +0.97 (+1.17%)
     

  • GOLD

    2,344.10
    +5.70 (+0.24%)
     

Actinic Keratosis Epidemiology Guide 2021: 10-year Forecasts of Actinic Keratosis Epidemiology to 2030

Research and Markets
·3-min read

Dublin, Dec. 06, 2021 (GLOBE NEWSWIRE) -- The "Actinic Keratosis - Epidemiology Forecast to 2030" report has been added to ResearchAndMarkets.com's offering.

This report delivers an in-depth understanding of the Actinic Keratosis, historical and forecasted epidemiology in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.

Actinic Keratosis Epidemiology
The Actinic Keratosis epidemiology division provides insights about the historical and current patient pool along with the forecasted trend for every seven major countries. It helps recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. This part of The report also provides the diagnosed patient pool and their trends along with assumptions undertaken.

Key Findings
The disease epidemiology covered in the report provides historical as well as forecasted Actinic Keratosis epidemiology segmented as the Total Diagnosed Prevalence of Actinic Keratosis, Gender-based Prevalence of Actinic Keratosis, and Age-based Prevalence of Actinic Keratosis. The report includes the Prevalent scenario of Actinic Keratosis in 7MM covering the United States, EU5 countries (Germany, France, Italy, Spain, and the United Kingdom), and Japan from 2018 to 2030.


Scope of the Report

  • Actinic Keratosis report covers a detailed overview explaining its causes, symptoms, classification, pathophysiology, diagnosis, and treatment patterns

  • Actinic Keratosis Epidemiology Report and Model provide an overview of the risk factors and global trends of Actinic Keratosis in the seven major markets (7MM: US, France, Germany, Italy, Spain, UK, and Japan)

  • The report provides insight into the historical and forecasted patient pool of Actinic Keratosis in the seven major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan

  • The report helps recognize the growth opportunities in the 7MM concerning the patient population

  • The report assesses the disease risk and burden and highlights the unmet needs of Actinic Keratosis

  • The report provides the segmentation of the Actinic Keratosis epidemiology by prevalent Cases of Actinic Keratosis in 7MM

  • The report provides the segmentation of the Actinic Keratosis epidemiology by Total diagnosed Prevalence of Actinic Keratosis, Prevalence of Actinic Keratosis based on Gender specific factors, Age-specific cases of Actinic Keratosis in 7MM

Report Highlights

  • 10-year Forecast of Actinic Keratosis epidemiology

  • 7MM Coverage

  • Total Diagnosed Prevalent Cases of Actinic Keratosis

  • Prevalent Cases of Actinic Keratosis based on age-specific Factors

  • Gender-specific Prevalence of Actinic Keratosis

ADVERTISEMENT


Key Questions Answered

  • What will be the growth opportunities in the 7MM concerning the patient population about Actinic Keratosis?

  • What are the Key Findings of Actinic Keratosis epidemiology across 7MM, and which country will have the highest number of patients during the forecast period (2021-2030)?

  • What would be the total number of patients with Actinic Keratosis across the 7MM during the forecast period (2021-2030)?

  • Among the EU5 countries, which country will have the highest number of patients during the forecast period (2021-2030)?

  • At what CAGR the patient population is expected to grow by 7MM during the forecast period (2021-2030)?

  • What are the disease risk, burden, and unmet needs of Actinic Keratosis?

  • What are the currently available treatments for Actinic Keratosis?

Key Assessments

  • Patient Segmentation

  • Disease Risk and Burden

  • Risk of disease by the segmentation

  • Factors driving growth in a specific patient population

Geographies Covered

  • The United States

  • EU5 (Germany, France, Italy, Spain, and the United Kingdom)

  • Japan


For more information about this report visit https://www.researchandmarkets.com/r/rsif4v

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900